Greg- Who really knows what will happen. Let's not forget about the spinoff. I'm still unclear how that will work. How many shares of each entity we will get, how will this impact up listing/share price. I'm assuming this is why they want authorization to increase share count? Are we going to partner after the CLIA results and with whom and how much upfront cash. Even though many questions remain, I'm 100% positive that we are in good hands with our management team! We will have a lot of answers by the end of the month and year
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links